In this whitepaper, we take a look at how the pandemic has affected the mental health of the general public.

November is a time to think about how far we’ve come in COPD treatment — and how research can help us discover a cure.

There are many different approaches you can take to try to reach patients who will be the right fit for your study. Here are seven common pitfalls that won’t work for recruitment.

Most clinical trial sponsors are turning to online patient recruitment. But is it enough?

Our latest whitepaper asks the question, what does clinical research look like in a post-COVID world?

We’re thrilled to share that Antidote’s Executive Vice President of Business Development, Dave Mauro, has been named to this year’s PharmaVOICE 100.

We’re honored to announce that Antidote has been named a Scrip Awards finalist in the category of “Best Technological Development in Clinical Trials.”

In the United States today, there are 75 lupus trials looking for patients. These lupus clinical trials need more than 50,000 people to take part. If just 3.3% of the 1.5 million Americans living with lupus took part in a trial, imagine the progress that could be made.

In our latest whitepaper, we compare digital and human customer engagement, taking a close look at the impact both can have on patients looking for clinical trials.

Join us on November 6 at 1pm ET as Antidote’s Head of Partnerships, Lindsey Wahlstrom-Edwards, discusses the results of our recent survey of 4,000 patients — and what they mean for patient recruitment — during a live webinar.

The need for changes in the way patients are recruited is clear, which is why we’re sharing five ways to drive innovative patient recruitment in 2020.

Successful patient recruitment strategies anticipate the questions patients will ask and use a combination of different outreach methods to reach them where they are.